212 related articles for article (PubMed ID: 29773266)
21. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
Jiang J; Zhao M; Chang C; Wu H; Lu Q
Clin Rev Allergy Immunol; 2020 Oct; 59(2):248-272. PubMed ID: 32557263
[TBL] [Abstract][Full Text] [Related]
22. Aicardi-Goutières syndrome.
Crow YJ
Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
[TBL] [Abstract][Full Text] [Related]
23. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.
Melki I; Frémond ML
Curr Rheumatol Rep; 2020 Jun; 22(7):32. PubMed ID: 32548765
[TBL] [Abstract][Full Text] [Related]
24. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.
Cetin Gedik K; Lamot L; Romano M; Demirkaya E; Piskin D; Torreggiani S; Adang LA; Armangue T; Barchus K; Cordova DR; Crow YJ; Dale RC; Durrant KL; Eleftheriou D; Fazzi EM; Gattorno M; Gavazzi F; Hanson EP; Lee-Kirsch MA; Montealegre Sanchez GA; Neven B; Orcesi S; Ozen S; Poli MC; Schumacher E; Tonduti D; Uss K; Aletaha D; Feldman BM; Vanderver A; Brogan PA; Goldbach-Mansky R
Arthritis Rheumatol; 2022 May; 74(5):735-751. PubMed ID: 35315249
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
[TBL] [Abstract][Full Text] [Related]
26. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.
Cetin Gedik K; Lamot L; Romano M; Demirkaya E; Piskin D; Torreggiani S; Adang LA; Armangue T; Barchus K; Cordova DR; Crow YJ; Dale RC; Durrant KL; Eleftheriou D; Fazzi EM; Gattorno M; Gavazzi F; Hanson EP; Lee-Kirsch MA; Montealegre Sanchez GA; Neven B; Orcesi S; Ozen S; Poli MC; Schumacher E; Tonduti D; Uss K; Aletaha D; Feldman BM; Vanderver A; Brogan PA; Goldbach-Mansky R
Ann Rheum Dis; 2022 May; 81(5):601-613. PubMed ID: 35086813
[TBL] [Abstract][Full Text] [Related]
27. Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling.
Hansen AL; Buchan GJ; Rühl M; Mukai K; Salvatore SR; Ogawa E; Andersen SD; Iversen MB; Thielke AL; Gunderstofte C; Motwani M; Møller CT; Jakobsen AS; Fitzgerald KA; Roos J; Lin R; Maier TJ; Goldbach-Mansky R; Miner CA; Qian W; Miner JJ; Rigby RE; Rehwinkel J; Jakobsen MR; Arai H; Taguchi T; Schopfer FJ; Olagnier D; Holm CK
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7768-E7775. PubMed ID: 30061387
[TBL] [Abstract][Full Text] [Related]
28. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.
Munoz J; Rodière M; Jeremiah N; Rieux-Laucat F; Oojageer A; Rice GI; Rozenberg F; Crow YJ; Bessis D
JAMA Dermatol; 2015 Aug; 151(8):872-7. PubMed ID: 25992765
[TBL] [Abstract][Full Text] [Related]
29. Development of a Validated Interferon Score Using NanoString Technology.
Kim H; de Jesus AA; Brooks SR; Liu Y; Huang Y; VanTries R; Montealegre Sanchez GA; Rotman Y; Gadina M; Goldbach-Mansky R
J Interferon Cytokine Res; 2018 Apr; 38(4):171-185. PubMed ID: 29638206
[TBL] [Abstract][Full Text] [Related]
30. Dirty Fish Versus Squeaky Clean Mice: Dissecting Interspecies Differences Between Animal Models of Interferonopathy.
Rutherford HA; Kasher PR; Hamilton N
Front Immunol; 2020; 11():623650. PubMed ID: 33519829
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.
Lin B; Goldbach-Mansky R
J Allergy Clin Immunol; 2022 Mar; 149(3):819-832. PubMed ID: 34893352
[TBL] [Abstract][Full Text] [Related]
32. Aicardi-Goutières syndrome (AGS).
Stephenson JB
Eur J Paediatr Neurol; 2008 Sep; 12(5):355-8. PubMed ID: 18343173
[TBL] [Abstract][Full Text] [Related]
33. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations.
Ramantani G; Häusler M; Niggemann P; Wessling B; Guttmann H; Mull M; Tenbrock K; Lee-Kirsch MA
J Child Neurol; 2011 Nov; 26(11):1425-8. PubMed ID: 21670392
[TBL] [Abstract][Full Text] [Related]
34. Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China.
Li W; Wang W; Wang W; Zhong L; Gou L; Wang C; Ma J; Quan M; Jian S; Tang X; Zhang Y; Wang L; Ma M; Song H
Front Immunol; 2022; 13():825367. PubMed ID: 35418997
[TBL] [Abstract][Full Text] [Related]
35. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans.
White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F
Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507
[TBL] [Abstract][Full Text] [Related]
36. Type I interferon in neurological disease-the devil from within.
Hofer MJ; Campbell IL
Cytokine Growth Factor Rev; 2013 Jun; 24(3):257-67. PubMed ID: 23548179
[TBL] [Abstract][Full Text] [Related]
37. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy.
Chia J; Eroglu FK; Özen S; Orhan D; Montealegre-Sanchez G; de Jesus AA; Goldbach-Mansky R; Cowen EW
J Am Acad Dermatol; 2016 Jan; 74(1):186-9. PubMed ID: 26584874
[TBL] [Abstract][Full Text] [Related]
38. Cardiac valve involvement in
Crow Y; Keshavan N; Barbet JP; Bercu G; Bondet V; Boussard C; Dedieu N; Duffy D; Hully M; Giardini A; Gitiaux C; Rice GI; Seabra L; Bader-Meunier B; Rahman S
J Med Genet; 2020 Jul; 57(7):475-478. PubMed ID: 31772029
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
[TBL] [Abstract][Full Text] [Related]
40. Characterization of samhd1 morphant zebrafish recapitulates features of the human type I interferonopathy Aicardi-Goutières syndrome.
Kasher PR; Jenkinson EM; Briolat V; Gent D; Morrissey C; Zeef LA; Rice GI; Levraud JP; Crow YJ
J Immunol; 2015 Mar; 194(6):2819-25. PubMed ID: 25672750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
